Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Kingfisher Leads FTSE 100 After Acquisition Setback

Mon, 30th Mar 2015 10:29

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Monday.
-------
FTSE 100 WINNERS
-------
Kingfisher, up 3.2%. The owner of B&Q and Screwfix said its deal to acquire Mr Bricolage will not proceed amid opposition from a shareholder and the board of the French company to the terms of the deal. Kingfisher entered into a deal in July last year to acquire Mr Bricolage for EUR275 million but it warned last week it may be under threat after ANPF, which holds a 41.9% stake in the business, and Mr Bricolage's board had reservations about the deal. Kingfisher said the deadline for gaining anti-trust clearance for the deal in France was March 31 and, as a result of the opposition to the deal from ANPF and the Mr Bricolage board, that deadline is no longer viable.

WPP, up 1.2% at 1,558.64 pence. UBS has lifted the advertising agency price target to 1,700p from 1,500p, reiterating its Buy rating.

Rolls-Royce Holdings, up 1.2%. The jet engine and power turbine company said Air China has selected the British company's Trent 1000 engines and its aftercare support to power 15 new Boeing 787-9 Dreamliner aircraft, building on a relationship the two companies already have and adding to Rolls-Royce's USD1 billion order book.
-------
FTSE 100 LOSERS
-------
CRH, down 1.3%. Eurocement Holding, a key shareholder in Holcim, plans to vote against the Swiss cement maker's merger with Lafarge unless the financial terms of the deal are altered, the Wall Street Journal said Sunday, quoting a person familiar with matter. Eurocement is the second-largest shareholder in Holcim with a 10.82% stake. CRH will acquire a large set of assets from the merged companies.

Wm Morrison Supermarkets, down 1.2% at 196.2p. Goldman Sachs has downgraded the supermarkets chain to Hold from Buy, cutting its price target to 205p from 207p.
-------
FTSE 250 LOSERS
-------
Al-Noor Hospitals Group, down 3.6%. The Abu Dhabi-based healthcare provider shares are down even though it said Monday its pretax profit rose to USD83.9 million from USD61.5 million in 2013, with revenue increasing 23% to USD449.1 million from USD365 million. The group raised its final dividend to 9 pence per share for 2014 to 12.7 pence per share, up 32% year-on-year. However, Numis has downgraded Al Noor Hospitals Group to Hold from Add as the shares have performed well in the run up to the results, but also saying that the consensus for the Abu Dhabi-based healthcare provider's margins is too high.
-------
AIM ALL-SHARE WINNERS
-------
Venn Life Sciences Holdings, up 10%. The company said it has signed contracts worth a total of EUR4.1 million with an unnamed US biotechnology company. Venn Life said the deals are an extension of an existing contract, which has now doubled in size, along with the award of a new clinical trial valued at EUR2.7 million.

Northcote Energy, up 7.6%. The US onshore-focused oil & gas company said it has entered into an agreement with Mexican oilfield and environmental services company Gaia Ecologica, under which the pair will work together on securing new contracts in the country, including oil field services, environmental remediation, waste water treatment to oil and gas development concessions and production sharing agreements. Profits from the joint ventures will be split 51% to Northcote and 49% to Gaia.
-------
AIM ALL-SHARE LOSERS
-------
Quadrise Fuels International, down 19%. The technology provider to the oil and gas industry said its pretax loss in the first half of the financial year widened after it was hit by increased costs and a share option charge, and admitted it has been "frustrating" that it did not progress more of its projects in 2014. The company reported a pretax loss of GBP2.2 million compared with a GBP1.8 million loss a year earlier. The loss widened as production and development costs rose to GBP552,000 from GBP342,000 and after it was hit by a GBP1.1 million share option charge.

Cloudbuy, down 11%. The cloud e-commerce company said its pretax loss widened significantly in 2014 on the back of investments made in its Asia Pacific expansion and due to lower revenue hit by sluggishness in its key markets. CloudBuy said its pretax loss for the year was GBP4.6 million, significantly wider than the GBP936,417 loss it posted a year earlier. The loss was driven by a combination of lower revenue, down to GBP2.1 million from GBP3 million, and by higher administrative expenses related to its expansion and subsequent headcount expansion in Asia Pacific.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
28 Jun 2019 13:21

Open Orphan Begins London Trading Following Venn Life Merger

(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Orphan DAC.Venn Life Sciences announced a

Read more
11 Jun 2019 10:51

WINNERS & LOSERS SUMMARY: Ted Baker Sinks After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5%, BHP Group, up up a

Read more
11 Jun 2019 10:31

Venn Life Sciences Raises GBP4.5 Million As Loss Widens In 2018 (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share placing as its loss widened in 2018.The a

Read more
10 May 2019 10:06

Venn Life Sciences To Acquire Open Orphan And Plans To Raise Funds (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it is acquiring Open Orphan DAC in an all-share acquisition and planning an equity fundraise.In addition, Venn it has

Read more
8 Apr 2019 12:11

Venn Life Sciences Secures GBP250,000 Loan From Chair Cathal Friel

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Monday said Raglan Capital Ltd, of whom Cathal Friel is a principal and owner, has subscribed for loan notes of GBP250,000 with a term -

Read more
18 Jan 2019 09:44

Venn Life Sciences Partners With Carrick To Develop Cancer Treatments

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it has collaborated with Carrick Therapeutics Ltd to develop innovative cancer treatments.The drug development said a

Read more
18 Jan 2019 08:19

Venn Life Sciences finds 'model client' in Carrick Therapeutics

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a partnership with Carrick Therapeutics on Friday.

Read more
11 Dec 2018 14:40

Venn Life Sciences shuffles board, partners with Open Orphan DAC

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a strategic collaboration with Open Orphan DAC, as well as the issue of £1m in privately-held loan notes on Tuesday, to fund an increased focus of the business into the high growth area of orphan diseases.

Read more
11 Dec 2018 12:59

Venn Life Sciences Teams With Open Orphan, Issues GBP1.0 Million Notes

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Tuesday it entered a strategic collaboration with Open Orphan DAC.Under the collaboration, both companies will commit to and to

Read more
25 Sep 2018 13:25

Venn Life Sciences Interim Loss Widens As Order Conversion Disappoints

LONDON (Alliance News) - Drug development firm Venn Life Sciences Holdings PLC said Tuesday its half-year loss widened as revenue dropped on delays to the conversion of orders to sales.For

Read more
30 Jul 2018 16:11

Spreadex Holds 5.5% Stake In Venn Life Sciences After Deal (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.Through a combination of contracts

Read more
4 Jul 2018 11:42

Venn Life Sciences Raises GBP650,000 To Fund German Acquisition (ALLISS)

LONDON (Alliance News) - Drug development partner to pharmaceutical companies Venn Life Sciences Holdings PLC said Wednesday it raised up to GBP650,000 issuing 10.8 million shares at 6 pence was a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
17 May 2018 14:32

Venn Life Sciences 2017 Loss Widens On Top Of Lower Revenue

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said on Thursday its loss for 2017 widened due to higher impairments on fixed asset investments, as well as lower revenue for the drug and

Read more
21 Mar 2018 11:03

Venn Life Sciences Searching For New Finance Chief As Hartshorn Leaves

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Wednesday that Finance Director Jonathan Hartshorn will leave the company, effective immediately, to pursue Venn

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.